CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.91 +0.04 (+4.42%)
As of: Oct 21, 2026 · 3:59 PM EDT

CytoMed Therapeutics (GDTC) Market Capitalization (2023 - 2026)

Updated

CytoMed Therapeutics' Market Capitalization came in at $12.18 million for Q2 2026, down 53.1% from $25.97 million a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Market Capitalization (2023 - 2026) Analysis & Trends

For FY2025, CytoMed Therapeutics' Market Capitalization was $15.85 million, down 59.6% from FY2024.

  • Going back by year, Market Capitalization was $39.24 million in FY2024 (-30.6%) and $56.55 million in FY2023.
  • Year-over-year, Market Capitalization increased in 1 of the last four quarters, with an average decline of 33.8%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.56 Bn 1,136.14 Bn 19.71 Bn
2 Johnson & Johnson 635.76 Bn 554.29 Bn 17.26 Bn
3 AbbVie 503.27 Bn 476.38 Bn 12.70 Bn
4 Merck 377.51 Bn 331.89 Bn 12.21 Bn
5 Novartis Ag 304.07 Bn 268.06 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.22 Bn 12.86 Bn
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn
8 Gilead Sciences 194.26 Bn 168.46 Bn 6.22 Bn
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn
10 CytoMed Therapeutics 10.29 Mn 1.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.18 Mn
Dec 31, 2025 15.85 Mn
Jun 30, 2025 25.97 Mn
Dec 31, 2024 39.24 Mn
Jun 30, 2024 24.00 Mn
Dec 31, 2023 56.55 Mn
Jun 30, 2023 24.14 Mn
API Access

CytoMed Therapeutics Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=GDTC&period=max&api_key=YOUR_API_KEY